Globus Historical Cash Flow
| GMED Stock | USD 50.75 0.45 0.88% |
Analysis of Globus Medical cash flow over time is an excellent tool to project Globus Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 106.5 M or Begin Period Cash Flow of 139.2 M as it is a great indicator of Globus Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Globus Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Globus Medical is a good buy for the upcoming year.
Globus |
About Globus Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Globus balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Globus's non-liquid assets can be easily converted into cash.
Globus Medical Cash Flow Chart
Globus Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Globus Medical Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At present, Globus Medical's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 152 M, whereas Free Cash Flow is forecasted to decline to about 106.5 M. Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Globus Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.At present, Globus Medical's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 152 M, whereas Free Cash Flow is forecasted to decline to about 106.5 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Free Cash Flow | 219.4M | 104.4M | 165.2M | 106.5M | Stock Based Compensation | 30.6M | 32.8M | 52.7M | 55.4M |
Globus Medical cash flow statement Correlations
Click cells to compare fundamentals
Globus Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Globus Medical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (50.0M) | (50.1M) | (12.0M) | (61.7M) | (70.3M) | (66.8M) | |
| Change In Cash | 56.0M | 43.7M | (46.3M) | (42.6M) | 316.8M | 332.7M | |
| Stock Based Compensation | 26.1M | 27.1M | 30.6M | 32.8M | 52.7M | 55.4M | |
| Free Cash Flow | 101.2M | 135.1M | 219.4M | 104.4M | 165.2M | 106.5M | |
| Change In Working Capital | (73.4M) | (37.6M) | (17.3M) | (105.3M) | (116.6M) | (110.8M) | |
| Begin Period Cash Flow | 139.7M | 195.7M | 239.4M | 193.1M | 150.5M | 139.2M | |
| Other Cashflows From Financing Activities | (6.6M) | (6.3M) | (9.3M) | (7.2M) | (18.7M) | (17.7M) | |
| Depreciation | 52.7M | 62.9M | 69.9M | 68.3M | 144.7M | 152.0M | |
| Other Non Cash Items | 7.1M | 48.5M | 61.5M | 14.7M | 97.5M | 102.4M | |
| Capital Expenditures | 70.8M | 63.7M | 56.9M | 74.0M | 78.3M | 49.9M | |
| Total Cash From Operating Activities | 172.0M | 198.8M | 276.3M | 178.5M | 243.5M | 156.4M | |
| Change To Account Receivables | (18.3M) | 10.7M | (25.9M) | (50.8M) | (49.9M) | (47.4M) | |
| Net Income | 155.2M | 102.3M | 149.2M | 190.2M | 122.9M | 117.5M | |
| Total Cash From Financing Activities | 24.4M | (38.7M) | 54.1M | (110.0M) | (231.8M) | (220.2M) | |
| End Period Cash Flow | 195.7M | 239.4M | 193.1M | 150.5M | 467.3M | 490.7M | |
| Sale Purchase Of Stock | 31.0M | (104.7M) | 63.5M | (144.5M) | (225.6M) | (214.3M) | |
| Total Cashflows From Investing Activities | (140.3M) | (117.3M) | (375.9M) | (110.4M) | (99.3M) | (104.3M) | |
| Other Cashflows From Investing Activities | (69.5M) | (33.5M) | (34.5M) | (31.4M) | (28.3M) | (29.7M) | |
| Change To Netincome | 37.5M | 71.3M | 71.9M | 22.6M | 26.0M | 34.2M | |
| Change To Liabilities | 773K | 12.9M | 26.8M | 17.6M | 20.3M | 10.9M | |
| Investments | (45.7M) | (20.2M) | (284.6M) | (4.9M) | (78.1M) | (82.0M) | |
| Change To Operating Activities | (5.2M) | 6.5M | 11.7M | (4.2M) | (4.8M) | (5.1M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.79) | Earnings Share 1.07 | Revenue Per Share 13.87 | Quarterly Revenue Growth 1.246 | Return On Assets 0.0477 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.